Ping An Healthcare and Technology Company Limited

SEHK:1833 Lagerbericht

Marktkapitalisierung: HK$7.2b

Ping An Healthcare and Technology Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Ping An Healthcare and Technology wird ein jährliches Gewinn- und Umsatzwachstum von 53.6% bzw. 7% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 51.6% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 0.9% betragen.

Wichtige Informationen

53.6%

Wachstumsrate der Gewinne

51.6%

EPS-Wachstumsrate

Consumer Retailing Gewinnwachstum28.8%
Wachstumsrate der Einnahmen7.0%
Zukünftige Eigenkapitalrendite0.9%
Analystenabdeckung

Good

Zuletzt aktualisiert20 Dec 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Ping An Healthcare and Technology Company Limited (HKG:1833) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

Nov 17
Ping An Healthcare and Technology Company Limited (HKG:1833) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

Ping An Healthcare and Technology Company Limited (HKG:1833) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected

Sep 27
Ping An Healthcare and Technology Company Limited (HKG:1833) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected

Ping An Healthcare and Technology Company Limited (HKG:1833) Shares Could Be 49% Below Their Intrinsic Value Estimate

Sep 20
Ping An Healthcare and Technology Company Limited (HKG:1833) Shares Could Be 49% Below Their Intrinsic Value Estimate

Ping An Healthcare and Technology Company Limited's (HKG:1833) Share Price Not Quite Adding Up

Jul 17
Ping An Healthcare and Technology Company Limited's (HKG:1833) Share Price Not Quite Adding Up

Revenues Not Telling The Story For Ping An Healthcare and Technology Company Limited (HKG:1833)

Apr 17
Revenues Not Telling The Story For Ping An Healthcare and Technology Company Limited (HKG:1833)

Ping An Healthcare and Technology (HKG:1833) Is In A Strong Position To Grow Its Business

Mar 20
Ping An Healthcare and Technology (HKG:1833) Is In A Strong Position To Grow Its Business

Calculating The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)

Jan 12
Calculating The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)

Getting In Cheap On Ping An Healthcare and Technology Company Limited (HKG:1833) Is Unlikely

Dec 22
Getting In Cheap On Ping An Healthcare and Technology Company Limited (HKG:1833) Is Unlikely

We're Hopeful That Ping An Healthcare and Technology (HKG:1833) Will Use Its Cash Wisely

Sep 27
We're Hopeful That Ping An Healthcare and Technology (HKG:1833) Will Use Its Cash Wisely

A Look At The Intrinsic Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)

Sep 10
A Look At The Intrinsic Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)

When Should You Buy Ping An Healthcare and Technology Company Limited (HKG:1833)?

Aug 02
When Should You Buy Ping An Healthcare and Technology Company Limited (HKG:1833)?

Here's Why We're Not Too Worried About Ping An Healthcare and Technology's (HKG:1833) Cash Burn Situation

Jun 26
Here's Why We're Not Too Worried About Ping An Healthcare and Technology's (HKG:1833) Cash Burn Situation

Ping An Healthcare and Technology Company Limited's (HKG:1833) Share Price Could Signal Some Risk

Jun 07
Ping An Healthcare and Technology Company Limited's (HKG:1833) Share Price Could Signal Some Risk

Is There An Opportunity With Ping An Healthcare and Technology Company Limited's (HKG:1833) 46% Undervaluation?

Apr 04
Is There An Opportunity With Ping An Healthcare and Technology Company Limited's (HKG:1833) 46% Undervaluation?

Should You Think About Buying Ping An Healthcare and Technology Company Limited (HKG:1833) Now?

Feb 16
Should You Think About Buying Ping An Healthcare and Technology Company Limited (HKG:1833) Now?

We Think Ping An Healthcare and Technology (HKG:1833) Can Afford To Drive Business Growth

Jan 23
We Think Ping An Healthcare and Technology (HKG:1833) Can Afford To Drive Business Growth

A Look At The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)

Jan 02
A Look At The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)

Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth

Oct 11
Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth

Estimating The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)

Sep 14
Estimating The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)

Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth

Jun 22
Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth

We're Hopeful That Ping An Healthcare and Technology (HKG:1833) Will Use Its Cash Wisely

Mar 01
We're Hopeful That Ping An Healthcare and Technology (HKG:1833) Will Use Its Cash Wisely

We're Not Very Worried About Ping An Healthcare and Technology's (HKG:1833) Cash Burn Rate

Nov 13
We're Not Very Worried About Ping An Healthcare and Technology's (HKG:1833) Cash Burn Rate

Are Ping An Healthcare and Technology Company Limited (HKG:1833) Investors Paying Above The Intrinsic Value?

Oct 18
Are Ping An Healthcare and Technology Company Limited (HKG:1833) Investors Paying Above The Intrinsic Value?

Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth

Aug 05
Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth

Are Ping An Healthcare and Technology Company Limited (HKG:1833) Investors Paying Above The Intrinsic Value?

Jul 10
Are Ping An Healthcare and Technology Company Limited (HKG:1833) Investors Paying Above The Intrinsic Value?

We Think Ping An Healthcare and Technology (HKG:1833) Can Afford To Drive Business Growth

Apr 04
We Think Ping An Healthcare and Technology (HKG:1833) Can Afford To Drive Business Growth

If You Had Bought Ping An Healthcare and Technology (HKG:1833) Shares A Year Ago You'd Have Earned 47% Returns

Feb 28
If You Had Bought Ping An Healthcare and Technology (HKG:1833) Shares A Year Ago You'd Have Earned 47% Returns

Are Institutions Heavily Invested In Ping An Healthcare and Technology Company Limited's (HKG:1833) Shares?

Jan 24
Are Institutions Heavily Invested In Ping An Healthcare and Technology Company Limited's (HKG:1833) Shares?

We Think Ping An Healthcare and Technology (HKG:1833) Can Easily Afford To Drive Business Growth

Dec 29
We Think Ping An Healthcare and Technology (HKG:1833) Can Easily Afford To Drive Business Growth

Does This Valuation Of Ping An Healthcare and Technology Company Limited (HKG:1833) Imply Investors Are Overpaying?

Dec 03
Does This Valuation Of Ping An Healthcare and Technology Company Limited (HKG:1833) Imply Investors Are Overpaying?

Gewinn- und Umsatzwachstumsprognosen

SEHK:1833 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (CNY Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20265,59025230645411
12/31/20255,44516818935213
12/31/20244,600118746813
6/30/20244,545-21-387-351N/A
3/31/20244,609-172-356-317N/A
12/31/20234,674-323-326-283N/A
9/30/20235,135-370-577-536N/A
6/30/20235,596-418-829-789N/A
3/31/20235,901-527-837-800N/A
12/31/20226,205-636-845-811N/A
9/30/20226,276-879-1,042-992N/A
6/30/20226,347-1,121-1,239-1,174N/A
3/31/20226,841-1,330-1,366-1,288N/A
12/31/20217,334-1,538-1,492-1,403N/A
9/30/20217,636-1,576-1,319-1,232N/A
6/30/20217,938-1,614-1,145-1,060N/A
3/31/20217,402-1,281-1,160-1,081N/A
12/31/20206,866-948-1,175-1,102N/A
9/30/20206,203-812-822-730N/A
6/30/20205,539-675-469-358N/A
3/31/20205,302-704-553-431N/A
12/31/20195,065-734-637-504N/A
9/30/20194,777-737-856-682N/A
6/30/20194,488-740-1,075-859N/A
3/31/20193,913-826-1,179-972N/A
12/31/20183,338-912-1,283-1,085N/A
9/30/20183,082-1,182-1,125-1,007N/A
6/30/20182,542-990-866-827N/A
3/31/20182,205-996N/A-655N/A
12/31/20171,868-1,002N/A-484N/A
9/30/20171,319-641N/A-531N/A
12/31/2016601-758N/A-263N/A
12/31/2015279-324N/A-45N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: 1833 wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (2.3%).

Ertrag vs. Markt: 1833 wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.

Hohe Wachstumserträge: 1833 wird voraussichtlich in den nächsten 3 Jahren rentabel werden.

Einnahmen vs. Markt: 1833Die Einnahmen des Unternehmens (7% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Hong Kong (7.8% pro Jahr).

Hohe Wachstumseinnahmen: 1833Die Einnahmen des Unternehmens (7% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: 1833Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (0.9%).

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2024/12/20 10:36
Aktienkurs zum Tagesende2024/12/20 00:00
Gewinne2024/06/30
Jährliche Einnahmen2023/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie hier mehr.

Analysemodell und Schneeflocke

Einzelheiten zum Analysemodell, das zur Erstellung dieses Berichts verwendet wurde, finden Sie auf unserer Github-Seite. Wir haben auch Anleitungen zur Verwendung unserer Berichte und Tutorials auf Youtube.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf .

Analysten-Quellen

Ping An Healthcare and Technology Company Limited wird von 25 Analysten beobachtet. 13 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
Xiaomeng ZhuangBofA Global Research
Shun Kei LawCCB International Securities Limited
Hazim BahariCFRA Equity Research